Action AEON AEON BIOPHARMA, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Autres langues AEON Biopharma, Inc. Nasdaq

Actions

AEON

US00775E1029

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
AEON Biopharma, Inc. Provides Update on Development Pipeline
US Equity Markets Close Higher Friday Following Weak Jobs Report
Sector Update: Health Care Stocks Mixed Late Afternoon
Sector Update: Health Care
Top Midday Decliners
Sector Update: Health Care Stocks Mixed Pre-Bell Friday
AEON Biopharma Shares Slump Pre-Bell After Failed Chronic Migraine Phase 2 Trial
AEON Biopharma Announces Preliminary Top-Line Results from Phase 2 Interim Analysis of ABP-450 in the Preventive Treatment of Chronic Migraine
AEON Biopharma, Inc. announced that it has received $15 million in funding from Daewoong Pharmaceutical Co., Ltd
Sector Update: Health Care Stocks Slide Late Afternoon
Sector Update: Health Care
AEON Biopharma Shares Tumble on Wider Q4 Loss
AEON Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
AEON Biopharma, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
AEON Biopharma, Inc. Announces Clinical Update and Productive End-of-Phase 2 Meeting with FDA on ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of Migraine
AEON Biopharma, Inc. announced that it expects to receive $15 million in funding from Daewoong Pharmaceutical Co., Ltd
Sector Update: Health Care Stocks Mixed Premarket Friday
AEON Biopharma Says Cervical Dystonia Treatment Well-Tolerated in Phase 2 Study
AEON Biopharma, Inc. Presents Positive Clinical and Pre-Clinical Data for ABP-450 (prabotulinumtoxinA) in Treating Cervical Dystonia and PTSD, Respectively, At TOXINS 2024
AEON Biopharma, Inc. Completes Enrollment in Phase 2 Study of ABP-450 (prabotulinumtoxinA) for Preventive Treatment of Chronic Migraine
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action AEON
  4. Action AEON
  5. Actualités AEON Biopharma, Inc.
  6. Autres langues